[1]
I, H. et al. 2024. ASSESSING CLINICAL OUTCOMES OF SGLT2 INHIBITOR THERAPY IN ELDERLY HFrEF PATIENTS WITH AND WITHOUT DIABETES: A SINGLE-CENTRE STUDY. Journal of the ASEAN Federation of Endocrine Societies. 39, S1 (Jul. 2024), 42. DOI:https://doi.org/10.15605/jafes.039.S1.066.